CD80 and focal segmental glomerulosclerosis: Expression of glomerular CD80 was observed in renal biopsies of FSGS and treatment with Abatacept, a fusion CTLA-4 Ig molecule that inhibits CD80, can induce partial or complete remission in post-transplant recurrence of FSGS [123, 124].